Preservation of renal function during gout treatment with febuxostat: a quantitative study.
about
Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men.Urate lowering therapy with febuxostat in daily practice-a multicentre, open-label, prospective observational study.Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trialsFebuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.Management of Gout and Hyperuricemia in CKD.Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat.As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.Recent pharmacological advances in the management of gout.Asymptomatic hyperuricemia: is it time to intervene?Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article.Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.
P2860
Q34029936-B4256F23-A057-4A36-B945-2A7CA2415455Q34207190-2D330E1D-F12B-49E1-8D8D-50B72ED8D7DBQ37607659-3A2CAD69-5C87-4E4E-A9C8-6A2AB7E08727Q38365938-93BCEB5B-1346-417C-B86C-EF639B53A0D8Q38812962-D876E25E-DEE6-4D00-AA4B-036C77D4E5D9Q39984416-70108FB5-E70E-41C1-A2E0-493B57743D73Q41444409-6E7F3E64-C082-45CE-A897-9F33400BA2FBQ42688139-BAE6B1D3-C086-45DA-B079-597AE19A9797Q45823744-782B8609-267A-4D1C-ADA0-094043ACCE92Q47163606-72869D24-C4A2-4A3B-91F4-EC83953E1661Q47919692-8864A2EB-E8CD-40AE-822B-67BA32DA57FCQ49588772-A4909B7A-AC05-43F5-8A7C-3B008509CE92Q52622926-8373C4F8-D099-4AD6-BC26-AE9B799D8043Q55284599-E47BFD3C-BF93-424A-9525-C832E007142F
P2860
Preservation of renal function during gout treatment with febuxostat: a quantitative study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Preservation of renal function ...... uxostat: a quantitative study.
@en
Preservation of renal function ...... uxostat: a quantitative study.
@nl
type
label
Preservation of renal function ...... uxostat: a quantitative study.
@en
Preservation of renal function ...... uxostat: a quantitative study.
@nl
prefLabel
Preservation of renal function ...... uxostat: a quantitative study.
@en
Preservation of renal function ...... uxostat: a quantitative study.
@nl
P2093
P2860
P356
P1476
Preservation of renal function ...... uxostat: a quantitative study.
@en
P2093
Andrew Whelton
Lhanoo Gunawardhana
Patricia A MacDonald
Solomon Chefo
P2860
P304
P356
10.3810/PGM.2013.01.2626
P407
P577
2013-01-01T00:00:00Z